phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptide
Quick Overview for phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptide (ABIN937185)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- CRSQQYPAAR PAEPRGQQVF LKPDEPPPQP CADSLQDALL SLGAVIDIAG
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Pde2 a antibody,
Alternative Names: Pde2a control peptide, Pde2a antibody Blocking Peptide, Anti-Pde2a Blocking Peptide, phosphodiesterase 2A, cGMP-stimulated Blocking Peptide, Pde2 Blocking Peptide, Pde2a2 Blocking Peptide, Pde2a Blocking Peptide, Pde2a, Pdea-2, Pdea 2, Pdea-2 Blocking Peptide, Pdea 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
-
Background
- The activation of Pde2a induces decreased cAMP accumulation, It is involved in nitric oxide mediated signaling in cardiac fibroblasts.
-
Molecular Weight
- 104 kDa
Target
-